$MSGS

JPMorgan Chase & Co. Issues Positive Forecast for Madison Square Garden (NYSE:MSGS) Stock Price

JPMorgan Chase & Co. has raised its target price for Madison Square Garden (NYSE:MSGS) stock from $240.00 to $305.00, maintaining an "overweight" rating and suggesting a potential upside of 9.24%. Despite this positive outlook, the stock currently holds a consensus "Hold" rating from multiple analysts with an average price target of $272.17. The company recently reported quarterly earnings of $0.34 per share, missing consensus estimates, but revenue exceeded expectations at $403.42 million.

Original reporting
MarketBeat · MarketBeat
Published Feb 6, 2026, 9:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Feb 6, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JPMorgan Chase & Co. Issues Positive Forecast for Madison Square Garden (NYSE:MSGS) Stock Price — source image
Decision brief

The 30-second read

$MSGSBullishMed
01

Why it matters

The analyst upgrade may lead to increased buying interest, but earnings miss warrants caution.

02

Market read

The news is relevant for investors interested in the entertainment, sports, and financial sectors, especially those holding MSGS or related assets.

03

What to watch

Potential market volatility due to broader economic factors or sector-specific risks that could negate positive forecasts.

Timing: short-term (next 1-3 months)

Background

JPMorgan's positive forecast follows MSGS's recent earnings report, which showed revenue exceeding expectations despite a earnings per share miss.

Company-level read

Ticker impact

$MSGSBullishMedium confidence
Context

The news pertains directly to Madison Square Garden (NYSE:MSGS), with a positive forecast and recent earnings report.

Expected impact

Potential short-term upward movement towards the new target price of $305, with a moderate probability (~60%) of reaching or surpassing this level within 3 months.

Evidence & confidence

The positive forecast and increased target price suggest bullish sentiment; however, earnings miss introduces some caution. Technical levels and market conditions should be monitored for confirmation.

$JPMNeutralHigh confidence
Context

JPMorgan's forecast influences market sentiment but has limited direct impact on JPM stock itself.

Expected impact

Minimal impact expected on JPM stock price.

Evidence & confidence

The forecast pertains to MSGS, not JPM, and does not affect JPM's fundamentals.

Market effects

The forecast may boost investor confidence in entertainment and sports sectors.

Limited regional impact; primarily relevant to US markets.

Low; sector-specific news with limited global implications.

Counterpoint

The earnings miss could signal underlying issues, and the optimistic target may be overly aggressive.

Key entities

  • Madison Square Garden

    A sports and entertainment company with a focus on venue management and media.

  • JPMorgan Chase & Co.

    A leading global financial services firm providing investment banking, asset management, and other financial services.

Related articles

$MSGSMed

Aviva, Frasers and Cohort: Markets live

Aviva (AV.) reported H1 operating profit up 24% to £1.3bn, driven by general insurance profit up 40% to £905mn from Direct Line integration, and raised its interim dividend 7% to 14p. It restarted buybacks and generated £100mn run-rate synergies. GB Group (GBG) shares fell after higher-than-expected US attrition and guidance cut. Frasers (FRAS) bought Harvey Nichols stores from administration. Cohort (CHRT) said Elac won a €141mn Saab sonar contract. Madison Square Garden Sports (MSGS) saw reven

$MSGSMed

Knicks’ title run boosts MSG Sports revenue

Madison Square Garden Sports Corp. said the Knicks’ championship run boosted Q4 and full-year results. Playoff-related revenue rose $66.9M year over year, helped by higher per-game playoff revenue and merchandise sales. FY 2026 revenue increased to $1.15B (+$114.6M). Q4 revenue rose to $278.7M (+37%).

$MSGSMed

Madison Square Garden Sports Corp. (MSGS): Results of Operations and Financial Condition

Madison Square Garden Sports Corp. (MSGS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 msgsportscorpex991forearni.htm EX-99.1 Document MADISON SQUARE GARDEN SPORTS CORP. REPORTS FISCAL 2026 FOURTH QUARTER AND FULL-YEAR RESULTS Fiscal 2026 Highlighted by the New York Knicks Winning the NBA Championship Proposed Spin-off of New York Rangers Business Expecte

$RYMedAI 8/10

Moneris sale to U.S. owner adds risk to Canada’s data sovereignty, payments industry leaders warn

RBC and BMO said they agreed to jointly sell Moneris Solutions Corp. to California-based Francisco Partners for about $2 billion in cash, with each lender taking a 50% share. The deal raises Canadian data sovereignty concerns. Moneris processes over $5 billion in transactions annually across 325,000 commerce points; regulatory approvals are needed, with expected close by end of fiscal Q1 2027.

$METAMed

Futures Erase Overnight Gains As Oil Hits One-Week High, Yen Slides

US equity futures largely gave back overnight gains after oil hit a one-week high and the yen weakened. Traders await US CPI and PPI, with rate-hike bets cooling after Friday’s jobs report. JPMorgan raised its S&P 500 year-end target to 8000. Corporate movers include AAON (+8%), ABCL (+22%), HZO halted on a $53 buyout, and VREX surging on Teledyne’s $18.90 offer.

$JPMMed

Wall Street Giants Are Facing a Reckoning After a New Report Links Their Silence to Epstein’s Ability To Fund His Operations

A Senate Democrats Finance Committee report, cited by NPR, alleges that JPMorgan Chase, Bank of America, and Deutsche Bank knew of suspicious transactions linked to Jeffrey Epstein for years but delayed filing suspicious activity reports. The report cites Treasury documents and bank records, saying Epstein moved over $1 billion. Deutsche Bank and Bank of America deny wrongdoing; JPMorganChase did not comment.